Form4insider filings, from the source

SEC Form 4 · accession 0001140361-18-008869

IDEXX LABORATORIES INC /DE · IDXX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jonathan W Ayers
Officer — Chairman, President & CEO · Director
Period of report
Feb 14, 2018
Accepted (ET)
Feb 16, 2018 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 14, 2018M2,160$0.00A1,061,272D
Common StockFeb 14, 2018M1,774$0.00A1,063,046D
Common StockF1Feb 14, 2018F1,828$178.26D1,061,218D
Common Stockholding———98,000Iby Ayers Family Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right-to-buy)F6,F2$178.26Feb 14, 2018A90,816A—Feb 13, 2028Common Stock90,81690,816D
Incentive Stock Option (right-to-buy)F6,F3$178.26Feb 14, 2018A560A—Feb 13, 2028Common Stock560560D
Restricted Stock UnitF6,F4—Feb 14, 2018M2,160D——Common Stock2,1603,548D
Restricted Stock UnitF6,F5—Feb 14, 2018M1,774D——Common Stock1,7741,774D

Explanation of responses